Previous close | 229.00 |
Open | 229.80 |
Bid | 210.00 x 900 |
Ask | 259.98 x 1200 |
Day's range | 226.44 - 237.62 |
52-week range | 161.65 - 275.00 |
Volume | |
Avg. volume | 533,600 |
Market cap | 11.986B |
Beta (5Y monthly) | 1.41 |
PE ratio (TTM) | 25.21 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
ICLR vs. CRL: Which Stock Is the Better Value Option?
Growth across Microbial Solutions and Biologics Testing businesses is likely to have contributed to Charles River's (CRL) Q1 revenues, offset by lower sales volume in the small model business.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.